This patent teaches how to administer bone marrow in vivo, so that administration is performed not only of hematopoietic stem cells, but also stromal elements. This combination should be useful in patients whose stroma has been destroyed for one reason or another. The invention may also be useful for prevention of donor-derived leukemic relapse.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.